ENTITY
BGI Genomics

BGI Genomics (300676 CH)

34
Analysis
Health CareChina
BGI Genomics Co., Ltd offers researching and testing services. The Company provides deoxyribonucleic acid sequencing, food science, health care researching, cancer prevention, drug discovery, and DNA sequencing. BGI Genomics offers services to medical and scientific research institutions worldwide.
more
Refresh
20 May 2022 08:57

Pre-IPO ADICON Holdings Limited - Uncertain Growth and Outlook in Post-COVID Era

The unsustainable COVID-19 related revenue will put pressure on ADICON's performance in post-COVID era. It's difficult to make breakthrough due to...

Logo
391 Views
Share
bullishSG Micro
04 May 2022 07:56

CSI300 Index Rebalance Preview: 30 Potential Changes as Sector Rotation Continues

We forecast 30 changes at the June rebalance for the CSI300 Index - most high probability. Industrials, IT and Materials sectors will have net...

Logo
635 Views
Share
06 Apr 2022 04:57

CSI300 Index Rebalance Preview (June): Maxing Out the 30 Changes

We estimate 30 changes at the June rebalance with a one-way turnover of 4.48% leading to a one-way trade of CNY 7.86bn. The potential adds have...

Logo
421 Views
Share
bullishTBEA Co Ltd A
17 Jan 2022 07:10

CSI300 Index Rebalance Preview (June 2022): Changes Near the Midway Mark

Nearly midway through the review period for the June rebalance of the CSI300 index, we see 29 potential changes resulting in a one-way turnover of...

Logo
595 Views
Share
20 Sep 2021 09:01

China Healthcare Weekly (Sep17) - A New Round of Rebalancing, Artificial Joints VBP, Genetic Testing

The article mainly analyzed the logic of volume-based purchase (VBP) and healthcare sector rebalancing, the results of centralized procurement of...

Logo
233 Views
Share
x